microRNA information: hsa-miR-219a-1-3p
| Section | ID | link |
|---|---|---|
| Mature name: | hsa-miR-219a-1-3p | miRbase |
| Accession: | MIMAT0004567 | miRbase |
| Precursor name: | hsa-mir-219a-1 | miRbase |
| Precursor accession: | MI0000296 | miRbase |
| Symbol: | NA | HGNC |
| RefSeq ID: | NA | GenBank |
| Sequence: | AGAGUUGAGUCUGGACGUCCCG |
Reported expression in cancers: hsa-miR-219a-1-3p
| miRNA | cancer | regulation | reporting | PUBMED | method |
|---|
Reported cancer pathway affected by hsa-miR-219a-1-3p
| miRNA | cancer | pathway | reporting | PUBMED | functional study |
|---|
Reported cancer prognosis affected by hsa-miR-219a-1-3p
| miRNA | cancer | prognosis | reporting | PUBMED | functional study |
|---|
Reported gene related to hsa-miR-219a-1-3p
| miRNA | cancer | gene | reporting | PUBMED |
|---|
Expression profile in cancer corhorts:
Putative target regulations
| miRNA | Gene | Cancer | Interaction | Correlation beta |
|---|---|---|---|---|
hsa-miR-219a-1-3p | ELL2 | 10 cancers: BLCA; ESCA; HNSC; KIRP; LUAD; LUSC; OV; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.129; TCGA ESCA -0.246; TCGA HNSC -0.164; TCGA KIRP -0.25; TCGA LUAD -0.086; TCGA LUSC -0.088; TCGA OV -0.188; TCGA SARC -0.235; TCGA STAD -0.19; TCGA UCEC -0.181 |
hsa-miR-219a-1-3p | GNGT2 | 12 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.444; TCGA CESC -0.205; TCGA ESCA -0.275; TCGA HNSC -0.218; TCGA KIRP -0.238; TCGA LIHC -0.261; TCGA LUAD -0.171; TCGA LUSC -0.503; TCGA OV -0.119; TCGA THCA -0.326; TCGA STAD -0.153; TCGA UCEC -0.112 |
hsa-miR-219a-1-3p | GBP2 | 13 cancers: BLCA; CESC; COAD; ESCA; HNSC; LIHC; LUAD; LUSC; OV; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.143; TCGA CESC -0.183; TCGA COAD -0.155; TCGA ESCA -0.275; TCGA HNSC -0.242; TCGA LIHC -0.142; TCGA LUAD -0.111; TCGA LUSC -0.256; TCGA OV -0.215; TCGA SARC -0.644; TCGA THCA -0.79; TCGA STAD -0.223; TCGA UCEC -0.251 |
hsa-miR-219a-1-3p | TMOD1 | 12 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LUAD; LUSC; OV; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.304; TCGA CESC -0.187; TCGA COAD -0.332; TCGA ESCA -0.505; TCGA HNSC -0.469; TCGA KIRP -0.505; TCGA LUAD -0.162; TCGA LUSC -0.322; TCGA OV -0.19; TCGA SARC -0.589; TCGA STAD -0.447; TCGA UCEC -0.25 |
hsa-miR-219a-1-3p | ARRB1 | 11 cancers: BLCA; CESC; ESCA; HNSC; KIRP; LGG; LUAD; LUSC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.221; TCGA CESC -0.187; TCGA ESCA -0.183; TCGA HNSC -0.251; TCGA KIRP -0.306; TCGA LGG -0.163; TCGA LUAD -0.11; TCGA LUSC -0.505; TCGA THCA -0.207; TCGA STAD -0.225; TCGA UCEC -0.118 |
hsa-miR-219a-1-3p | GPR171 | 11 cancers: BLCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; OV; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.579; TCGA CESC -0.31; TCGA ESCA -0.347; TCGA HNSC -0.186; TCGA LIHC -0.254; TCGA LUAD -0.213; TCGA LUSC -0.502; TCGA OV -0.369; TCGA SARC -0.276; TCGA THCA -0.691; TCGA UCEC -0.153 |
hsa-miR-219a-1-3p | GBP4 | 9 cancers: BLCA; ESCA; HNSC; KIRP; LUAD; LUSC; SARC; THCA; UCEC | MirTarget | TCGA BLCA -0.286; TCGA ESCA -0.294; TCGA HNSC -0.183; TCGA KIRP -0.613; TCGA LUAD -0.114; TCGA LUSC -0.455; TCGA SARC -0.229; TCGA THCA -0.262; TCGA UCEC -0.156 |
hsa-miR-219a-1-3p | JAZF1 | 9 cancers: BLCA; CESC; COAD; ESCA; HNSC; LUAD; LUSC; STAD; UCEC | MirTarget | TCGA BLCA -0.448; TCGA CESC -0.285; TCGA COAD -0.299; TCGA ESCA -0.244; TCGA HNSC -0.262; TCGA LUAD -0.18; TCGA LUSC -0.336; TCGA STAD -0.353; TCGA UCEC -0.22 |
hsa-miR-219a-1-3p | ASPN | 15 cancers: BLCA; CESC; COAD; ESCA; HNSC; KIRP; LIHC; LUAD; LUSC; OV; PAAD; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.849; TCGA CESC -0.465; TCGA COAD -0.56; TCGA ESCA -0.424; TCGA HNSC -0.372; TCGA KIRP -0.681; TCGA LIHC -0.425; TCGA LUAD -0.273; TCGA LUSC -0.397; TCGA OV -0.565; TCGA PAAD -0.252; TCGA SARC -0.344; TCGA THCA -0.583; TCGA STAD -0.36; TCGA UCEC -0.599 |
hsa-miR-219a-1-3p | ATP6V1B2 | 10 cancers: BLCA; ESCA; HNSC; LGG; LIHC; LUAD; LUSC; OV; SARC; THCA | MirTarget | TCGA BLCA -0.124; TCGA ESCA -0.064; TCGA HNSC -0.058; TCGA LGG -0.105; TCGA LIHC -0.064; TCGA LUAD -0.104; TCGA LUSC -0.175; TCGA OV -0.102; TCGA SARC -0.075; TCGA THCA -0.23 |
hsa-miR-219a-1-3p | NECAB1 | 12 cancers: BLCA; CESC; COAD; ESCA; LGG; LIHC; LUAD; LUSC; PAAD; SARC; STAD; UCEC | MirTarget | TCGA BLCA -0.427; TCGA CESC -0.24; TCGA COAD -0.64; TCGA ESCA -0.441; TCGA LGG -0.28; TCGA LIHC -0.265; TCGA LUAD -0.145; TCGA LUSC -0.449; TCGA PAAD -0.188; TCGA SARC -0.35; TCGA STAD -0.811; TCGA UCEC -0.219 |
hsa-miR-219a-1-3p | IKZF1 | 12 cancers: BLCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; OV; SARC; THCA; STAD; UCEC | MirTarget | TCGA BLCA -0.62; TCGA CESC -0.25; TCGA ESCA -0.265; TCGA HNSC -0.134; TCGA LIHC -0.301; TCGA LUAD -0.214; TCGA LUSC -0.557; TCGA OV -0.188; TCGA SARC -0.183; TCGA THCA -0.584; TCGA STAD -0.217; TCGA UCEC -0.173 |
hsa-miR-219a-1-3p | TFEC | 9 cancers: BLCA; CESC; ESCA; HNSC; LIHC; LUAD; LUSC; SARC; THCA | MirTarget | TCGA BLCA -0.608; TCGA CESC -0.179; TCGA ESCA -0.37; TCGA HNSC -0.221; TCGA LIHC -0.309; TCGA LUAD -0.25; TCGA LUSC -0.555; TCGA SARC -0.165; TCGA THCA -0.629 |
hsa-miR-219a-1-3p | TBC1D9 | 10 cancers: COAD; ESCA; KIRP; LGG; LIHC; LUAD; LUSC; OV; THCA; STAD | MirTarget | TCGA COAD -0.16; TCGA ESCA -0.165; TCGA KIRP -0.236; TCGA LGG -0.097; TCGA LIHC -0.159; TCGA LUAD -0.097; TCGA LUSC -0.123; TCGA OV -0.074; TCGA THCA -0.261; TCGA STAD -0.212 |
Enriched cancer pathways of putative targets